Kasvu Therapeutics Oy
3367901-3ActiveDeveloping novel small molecule drugs targeting TrkB for brain disorders.
Drug Development Companykasvutx.com
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 2023
- Grundat
Nyckelbeslutsfattare
Eero Castrén
Co-founder, Board member Professor, Research Director
Rafael Moliner
Co-founder, Biology Lead
Giray Enkavi
Co-founder, Principal Scientist Modeling
Matti Karvonen
Chief Medical Officer
+5 fler kontakter i Funnelfeedr
Beskrivning
Kasvu is a drug development company focused on harnessing the power of neuroplasticity to address major global mental health challenges. They specialize in creating first and best-in-class small molecule neuroplastogens designed to treat conditions involving altered neuronal connectivity. Their prim...
ScandiBio Therapeutics AB